Am J Surg Pathol

1. KOLIN DL, Mata DA, Lin DI, Ellenson LH, et al
   FGFR1 Mutations Are Rare Alternate Oncogenic Drivers in FOXL2-Wildtype Adult Granulosa Cell Tumors of the Ovary.
   Am J Surg Pathol. 2025 Oct 23. doi: 10.1097/PAS.0000000000002473.
   

   >> Share

   
   

   
   BMC Cancer

2. KIM JY, Shin HY, Haque R, Kang ES, et al
   PLCD1 expression for early detection and prognosis in High-Grade serous ovarian cancer.
   BMC Cancer. 2025;25:1741.
   

   >> Share

   
   
3. WANG Y, Chao Q, Lu X, Zhou Y, et al
   Clinical features and prognostic factors of ovarian cancer brain metastases from ovarian cancer: a retrospective multicenter study of 129 cases.
   BMC Cancer. 2025;25:1729.
   

   >> Share

   
   

   
   Cancer Res

4. PRADHAN B, Oikkonen J, Zhang K, Botto JM, et al
   Dynamic and Ongoing De Novo L1 Retrotransposition Contributes to Genome Plasticity and Intrapatient Heterogeneity in Ovarian Cancer.
   Cancer Res. 2025 Nov 12. doi: 10.1158/0008-5472.CAN-24-4419.
   

   >> Share

   
   

   
   Gynecol Oncol

5. ARYASOMAYAJULA C, Johnson CR, Francoeur AA, Sia TY, et al
   Pathogenic germline variants among patients with ovarian cancer by self-reported ancestry: A commercial laboratory collaborative research registry study.
   Gynecol Oncol. 2025;204:1-8.
   

   >> Share

   
   
6. THAKER PH, Richardson DL, Hagemann AR, Holloway RW, et al
   Corrigendum to 'OVATION-2: A randomized phase I/II study evaluating the safety and efficacy of IMNN-001 (IL-12 gene therapy) with neo/adjuvant chemotherapy in patients newly-diagnosed with advanced epithelial ovarian cancer' [Gynecol Oncol 2025 Jun 19
   Gynecol Oncol. 2025;203:182-183.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share